Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Dario Pasquale Anobile"'
Autor:
Iris C. Salaroglio, Dimas Carolina Belisario, Muhlis Akman, Sofia La Vecchia, Martina Godel, Dario Pasquale Anobile, Giacomo Ortone, Sabrina Digiovanni, Simona Fontana, Costanzo Costamagna, Menachem Rubinstein, Joanna Kopecka, Chiara Riganti
Publikováno v:
Journal of Experimental & Clinical Cancer Research, Vol 41, Iss 1, Pp 1-24 (2022)
Abstract Background Solid tumors subjected to intermittent hypoxia are characterized by resistance to chemotherapy and immune-killing by effector T-lymphocytes, particularly tumor-infiltrating Vγ9Vδ2 T-lymphocytes. The molecular circuitries determi
Externí odkaz:
https://doaj.org/article/339f95a15a81485b9051ea494da23165
Autor:
Martina Godel, Giacomo Ortone, Dario Pasquale Anobile, Martina Pasino, Giulio Randazzo, Chiara Riganti, Joanna Kopecka
Publikováno v:
Pharmaceutics, Vol 13, Iss 5, p 762 (2021)
Drug resistance is the main obstacle for a successful cancer therapy. There are many mechanisms by which cancers avoid drug-mediated death, including alterations in cellular metabolism and apoptotic programs. Mitochondria represent the cell’s power
Externí odkaz:
https://doaj.org/article/7620cf8f0c1a46adbed878e15c7f0b37
Publikováno v:
Biochemical Society Transactions. 51:137-146
Antiviral RNA interference (RNAi) is an immune pathway that can, in certain conditions, protect mammalian cells against RNA viruses. It depends on the recognition and dicing of viral double-stranded RNA by a protein of the Dicer family, which leads t
Autor:
Chiara Riganti, Iris C. Salaroglio, Dimas Carolina Belisario, Muhlis Akman, Sofia La Vecchia, Martina Godel, Dario Pasquale Anobile, Giacomo Ortone, Sabrina Digiovanni, Simona Fontana, Costanzo Costamagna, Joanna Kopecka
Background. Solid tumors subjected to intermittent hypoxia are characterized by resistance to chemotherapy and immune-killing by effector T-lymphocytes, particularly tumor-infiltrating Vγ9Vδ2 T-lymphocytes. The molecular circuitries determining thi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d30e46157ba475fadeb795c014c3564a
https://doi.org/10.21203/rs.3.rs-1503033/v1
https://doi.org/10.21203/rs.3.rs-1503033/v1
Autor:
Riccardo Taulli, Marcello Francesco Lingua, Federica Di Nicolantonio, Alessandra Pittaro, Giorgio V. Scagliotti, Deborah Morena, Chiara Riganti, Roberta Libener, Federico Bussolino, Francesco Leo, Alberto Sandri, Mauro Papotti, Luisella Righi, Paolo Bironzo, Chiara Gigliotti, Valentina Comunanza, Silvia Novello, Francesco Guerrera, Francesca Napoli, Francesca Picca, Pablo M. Aviles, Dario Pasquale Anobile
Publikováno v:
Cancers
Volume 13
Issue 10
Cancers, Vol 13, Iss 2332, p 2332 (2021)
Volume 13
Issue 10
Cancers, Vol 13, Iss 2332, p 2332 (2021)
Simple Summary The marine drug lurbinectedin revealed an unprecedented efficacy against patient-derived malignant pleural mesothelioma cells, regardless of the histological type and the BAP1 mutation status. By inducing strong DNA damages, it dramati